OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?

Top 3 AI Stocks to Invest in Right Now

Fake shopping sprees and ‘happiness insurance’: The latest fintech apps reveal our financial anxieties

Is Apple’s foldable iPhone Duo worth $2,000? See how it stacks up against other foldable phones.

I gave my HomeExchange guest a 5-star review. Then I found heat marks all over my dining table. Do I call her out?

Inside the push to weaken Washington’s toughest financial watchdog

Scared to spend your retirement money? Here’s one way to get over the fear of running out.

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
3rdPartyFeeds • News

Currencies: Dollar attempts to snap 4-day skid as trade tensions subside

May 14, 2019

The U.S. dollar edged higher on Tuesday, attempting to snap a 4-day losing streak amid the back-and-forth trade dispute between the U.S. and China.

Read More...

3rdPartyFeeds

Marijuana Stocks: CannTrust Earnings Shows Big Revenue Gain; Aurora Cannabis, Tilray Due Late

May 14, 2019

CannTrust reported a loss and 115% revenue growth early Tuesday. Aurora Cannabis and Tilray are expected to report losses and big sales gains after the close...

3rdPartyFeeds

3 Ways Marijuana Stocks Are Tricking Investors

May 14, 2019

Though perfectly legal, these accounting tricks are masking the true operating results of many pot stocks. Read More...

3rdPartyFeeds

Cronos Group and MediPharm Labs Enter $30 Million Multi-Year Private Label Cannabis Concentrate Supply Agreement with Potential to Increase to $60 Million

May 14, 2019

MediPharm Labs Corp. (LABS.V) (MEDIF) (“MediPharm Labs”) a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, is pleased to...

3rdPartyFeeds

Cronos Group and MediPharm Labs Enter Cannabis Concentrate Supply Agreement

May 14, 2019

Cronos Group Inc. (CRON.TO) (CRON.TO) (“Cronos Group” or the “Company”), is pleased to announce that it has entered into a multi-year supply agreement with...

3rdPartyFeeds

Take-Two revenue forecast misses as competition from ‘Fortnite’ intensifies

May 14, 2019

Take-Two Interactive Software reported lower-than-expected revenue and forecast first-quarter sales below analysts' expectations. Read more...

3rdPartyFeeds

Google opens German center to improve data privacy

May 14, 2019

Google says it's opening a privacy focused engineering center in Munich, Germany, in its latest move to beef up its data protection credentials. CEO Sundar...

3rdPartyFeeds

Tencent Music charges for more content as paying users drive profit beat

May 14, 2019

China's Tencent Music Entertainment Group said it had started charging for more of its content in the first quarter as the popularity of its pay-for...

3rdPartyFeeds • News

Brett Arends’s ROI: The media is lying to you about Trump’s China tariffs

May 14, 2019

The hysteria must have a political agenda because the amount that’s being charged is peanuts.

Read More...

3rdPartyFeeds • News

Tim Mullaney: Now Trump is coming for your iPhone

May 14, 2019

President’s China tariffs cost American consumers and investors, writes Tim Mullaney.

Read More...

Previous 1 … 8,243 8,244 8,245 8,246 8,247 … 8,455 Next
Indices by TradingView

Top 3 AI Stocks to Invest in Right Now

October 18, 2026

Fake shopping sprees and ‘happiness insurance’: The latest fintech apps reveal our financial anxieties

October 17, 2026

Is Apple’s foldable iPhone Duo worth $2,000? See how it stacks up against other foldable phones.

October 17, 2026

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.